A comprehensive screening method for investigating the potential binding targets of doxorubicin based on protein...

Area of Science:

• Pharmacology
• Biotechnology
• Proteomics

Background:

• Precision therapy necessitates identifying drug targets to understand mechanisms and reduce side effects.
• Screening candidate proteins aids in predicting potential drug targets and toxicity.
• Protein microarrays offer a high-throughput approach for drug-target interaction studies.

Purpose of the Study:

• To develop and apply a high-throughput protein microarray for screening drug-binding proteins.
• To identify potential targets and understand the pharmacological effects of doxorubicin.
• To investigate doxorubicin's influence on protein-protein interactions.

Main Methods:

• Utilized a protein microarray containing over 21,000 human proteins for high-throughput screening.
• Employed bioinformatics analysis to interpret microarray data and identify binding affinities.
• Investigated the effect of doxorubicin on protein interactions, specifically the HRAS-RAF complex.

Main Results:

• Identified multiple potential protein targets with varying binding affinities to doxorubicin.
• HRAS was identified as a critical protein interacting with doxorubicin.
• Doxorubicin was found to promote the formation of the HRAS-RAF complex.

Conclusions:

• The protein microarray is effective for comprehensive pharmacological and toxicological investigations.
• HRAS is a key protein target for doxorubicin, influencing protein complex formation.
• Findings advance the understanding of doxorubicin's multifaceted effects and support broader applications of protein microarrays.